Status
Conditions
Treatments
About
Primary Objective: Evaluate how the Circadian OS iPad-based light intervention suppresses melatonin. This small pilot study is designed to validate the Circadian OS technology by testing physiological response using melatonin suppression. The study aims to evaluate how the Circadian OS iPad-based light intervention influences sleepiness as measured objectively via suppression of melatonin and subjectively via the Karolinska Sleepiness scale.
Full description
Aims: To test whether the Circadian OS app delivers sufficient circadian effective light that will result in measurable melatonin suppression (target suppression is 30% after 1 hour exposure)
Hypothesis: The Circadian OS app will deliver a Circadian Stimulus (CS) of 0.3 at the eye level and will result in 30% melatonin suppression after one hour using the device compared to less than 10% suppression without the Circadian OS app and the subjects will feel less sleepy (KSS score) when exposed to the Circadian OS app compared to no app
Outcomes: melatonin suppression will be calculated from saliva samples and subjective sleepiness as self-rated on the Karolinska Sleepiness Scale (KSS)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Healthy adults over the age of 30
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
10 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Barbara Plitnick
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal